Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer
Condition(s):Breast CancerLast Updated:November 16, 2021Recruiting
Include Studies Not Open or Pending
Condition(s):Breast CancerLast Updated:November 16, 2021Recruiting
Condition(s):Community-acquired Bacterial PneumoniaLast Updated:December 8, 2023Recruiting
Condition(s):Triple Negative Breast CancerLast Updated:November 8, 2022Recruiting
Condition(s):Post Operative EndophthalmitisLast Updated:January 9, 2024Not yet recruiting
Condition(s):Healthy ParticipantsLast Updated:March 15, 2024Recruiting
Condition(s):HealthyLast Updated:March 19, 2024Recruiting
Condition(s):HealthyLast Updated:February 20, 2024Recruiting
Condition(s):Tuberculosis; Human Immunodeficiency VirusLast Updated:August 25, 2023Recruiting
Condition(s):Overweight; ObesityLast Updated:March 19, 2024Recruiting
Condition(s):EndophthalmitisLast Updated:July 27, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.